Keratoonus study for early diagnosis and monitoring
Part of Eyes & vision clinical trials.
This study follows people with or at risk for keratoonus, a condition where the cornea thins and bulges. It aims to improve early detection and understand how the disease progresses.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 4 years old.
- You have not had eye surgery or major corneal scarring.
- You can understand and cooperate with eye exams and follow-up visits.
- You have no signs of keratoonus in either eye (for the suspected group) OR you have keratoonus in one eye but not the other (for the subclinical group) OR you have keratoonus in at least one eye (for the diagnosed group).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at why keratoconus gets worse quickly in children. You may help doctors understand how collagen affects the condition.
This study uses a special eye scan to look at the top layer of the cornea (the clear front of the eye) to help detect early signs of keratoconus, a condition where the cornea thins and bulges. It could help with early diagnosis and better treatment decisions.
This study looks at how people with keratoconus decide to take part in clinical research. It's for people who haven't had any treatment for keratoconus yet, and it may help improve future research studies for this condition.
This study looks at what leads to keratoconus and how it progresses over time. It may help doctors better predict worsening vision and plan earlier care.
This study tests whether a special eye scan called OCT can better identify causes of irregular cornea shape. Results may help doctors sort out different cornea problems so treatment choices, like certain procedures, can be more targeted.
This trial is for people who have keratoconus (a cornea condition that can blur vision). It involves receiving care or evaluation at the Homburg Keratoconus Center, and it may help by improving how keratoconus patients are managed.
Hear when a new Keratoconus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.